血脂论坛-2 一年四剂，长久心安
Hyperlipidemia Forum-2
11/22 15:30-17:30
206 (206)
-
15:30- 17:30
-
15:30- 17:30
-
15:40-15:45
-
15:30-15:40
-
16:00-16:20中国血脂药物研发布局及瑞卡西单抗研发之路The Layout of Lipid Drug Research and Development in China and the Road to the Research and Development of Recaticimab
-
16:20-16:40瑞卡西单抗-全球首个超长效PCSK9单抗Recaticimab - The World's First Ultra-long Acting PCSK9 Mab
-
16:40-16:55
-
16:55-17:10
-
17:10-17:30
-
15:45-16:00瑞卡西单抗III期临床试验研究者致谢Recaticimab Phase III Clinical Trial Investigator Thanks